Chemed CORP Form 4 insider transactions

NYSE
Executive Vice President Nicholas Westfall reports the vesting and acquisition of Chemed Corp stock and performance stock units (PSUs) based on performance achievements, along with shares withheld for tax obligations.
NYSE
VP & Chief Financial Officer of Chemed Corp, Michael D. Witzeman, reports acquisition and disposal of Chemed Capital Stock following the vesting of Performance Stock Units (PSUs).
NYSE
Chemed Corp's Vice President, Thomas C. Hutton, reports acquisition and disposal of company stock following the vesting of performance stock units (PSUs).
NYSE
Chemed Corp's CEO, Kevin McNamara, reports the vesting of performance stock units (PSUs) and subsequent stock transactions, including shares acquired, disposed of, and withheld for tax obligations.
NYSE
Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, reports the vesting and subsequent transactions of performance stock units (PSUs) based on company performance, along with the acquisition of new PSUs.
NYSE
Chemed Corp's VP and Chief Legal Officer, Brian C. Judkins, purchased 145 shares of company stock at $519.5 per share on December 30, 2024.
NYSE
Chemed Corp's VP and Chief Legal Officer, Brian C. Judkins, executed multiple transactions involving company stock and options on March 20, 2024, including the sale of 11,158 shares.
NYSE
Executive Vice President Spencer S. Lee of Chemed Corp sold 65 shares of capital stock on December 2, 2024.
NYSE
Executive Vice President of Chemed Corp, Spencer S. Lee, sold 732 shares of company stock at a price of $575.623 per share on November 27, 2024.
NYSE
Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of capital stock at a weighted average price of $572.77 on November 25, 2024.
NYSE
Executive Vice President of Chemed Corp, Spencer S. Lee, sold 1,000 shares of company stock at a price of $565.71 per share on November 22, 2024.
NYSE
Vice President Thomas C. Hutton of Chemed Corp reports the acquisition of stock options.
NYSE
Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, reports the acquisition of 10,323 stock options on October 22, 2024.
NYSE
Executive Vice President Spencer S. Lee acquired 9,105 stock options in Chemed Corp on October 22, 2024.
NYSE
Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, reports acquisition of stock options.
NYSE
Nicholas Michael Westfall, Executive Vice President of Chemed Corp, reports acquisition of stock options.
NYSE
Chemed Corp's CEO, Kevin J. McNamara, acquired 40,332 stock options on October 22, 2024, exercisable starting October 22, 2025.
NYSE
Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of company stock at an average price of $598.81 on September 26, 2024.
NYSE
Director George J. Walsh III of Chemed Corp (CHE) sold 400 shares of Capital Stock on September 26, 2024, at a price of $597.47 per share.
NYSE
Nicholas Michael Westfall, Executive Vice President of Chemed Corp, sold 1,713 shares of capital stock at an average price of $569.35 on September 9, 2024.
NYSE
Nicholas Westfall, Executive Vice President of Chemed Corp, exercised stock options and disposed of shares to cover the purchase price and tax obligations on September 4, 2024.
NYSE
Director Andrea R. Lindell sold 831 shares of Chemed Corp (CHE) at a price of $571.51 on August 16, 2024.
NYSE
Director George J. Walsh III of Chemed Corp reported the sale of 200 shares of Capital Stock on August 21, 2024.
NYSE
Thomas C. Hutton, a director and Vice President of Chemed Corp, amended a previous SEC filing to report the disposal of 4,827 shares of Capital Stock at a price of $576.32 on August 7, 2024.
NYSE
Executive Vice President Spencer S. Lee reports stock sales and option exercises at Chemed Corp.
NYSE
Thomas C. Hutton, Vice President of Chemed Corp, sold 4,827 shares of Capital Stock on August 6, 2024, at a price of $576.32 per share.
NYSE
Chemed Corp's CEO, Kevin McNamara, reports exercising stock options and selling shares on August 5, 2024.
NYSE
Chemed Corp's VP & Chief Financial Officer, Michael D. Witzeman, executed stock options and disposed of shares to cover the purchase price and tax obligations.
NYSE
Nicholas Westfall, Executive Vice President of Chemed Corp, amended a previous filing to report a sale of 2,000 shares of capital stock at an average price of $561.58.
NYSE
Nicholas Michael Westfall, Executive Vice President of Chemed Corp, sold 2,000 shares of capital stock at an average price of $561.58 on July 30, 2024.